UK Diabetes Care Devices Market Analysis and Forecasts to 2015

UK Diabetes Care Devices Market Analysis and Forecasts to 2015

Summary

GlobalData’s “UK Diabetes Care Devices Market Analysis and Forecasts to 2015” report provides key data, information and analysis on the UK diabetes care devices market. The report provides market landscape, competitive landscape and market trends information on two market categories – glucose monitoring and insulin delivery. The report provides comprehensive information on the key trends affecting these categories and provides key analytical insights on the market dynamics. The report also reviews the competitive landscape in terms of mergers and acquisitions, pipeline products and technology offerings.

Scope

- Forecasts & analysis of a key market within the medical device industry, diabetes care devices market, to 2015.
- Market segmentation of the diabetes care devices market in the United Kingdom (UK) into glucose monitoring and insulin delivery. Glucose monitoring further segmented into blood glucose meters and blood glucose test strips. Insulin delivery further segmented into insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories.
- Market Analysis from 2001 to 2008, including new updated 2008 data.
- Analysis of the leading companies and competitive landscape including 2008 company market share analysis.
- Analysis of key diabetes care pipeline products, new technologies and clinical trials.
- Insight into the key mergers and acquisitions (M&As), partnerships, venture capital and private equity investments.
- Qualitative analysis of market drivers, market limiters regulatory issues and future outlook.

Reasons to buy

- Understand what the new growth opportunities are within the UK diabetes care devices market.
- Develop a clear knowledge & understanding of the UK diabetes care devices competitor landscape and how this will change to 2015.
- Identify acquisition opportunities across the UK diabetes care devices market.
- Identify key winners and losers and who is best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 10
2.1 What Is This Report About? 10
3 Executive Summary 11
4 Definitions of Markets Covered in the Report 12
4.1 Diabetic Care Devices 12
4.2 Glucose Monitoring Devices 12
4.2.1 Blood Glucose Meters 12
4.2.2 Blood Glucose Strips 12
4.3 Insulin Delivery 12
4.3.1 Insulin Pens 12
4.3.2 Insulin Syringes 13
4.3.3 Insulin Pumps 13
4.3.4 Traditional Insulin Pump Accessories 13
5 Healthcare Sector Review 14
5.1 Healthcare Expenditure 14
5.2 Healthcare Infrastructure 17
5.3 Healthcare Policy 19
5.4 UK Healthcare Trade Statistics 20
6 Regulation System 21
6.1 Medical Equipment Approval Process 21
6.1.1 Classification of Medical Devices 21
6.1.2 Conformity Assessment Process 30
6.2 Medical Device approval fee 34
6.3 Post Market Surveillance (PMS) 35
7 Pricing and Reimbursement 36
7.1 Market Pricing 36
7.2 Government Policies for Reimbursement 36
8 Distribution Structure 38
9 Diabetes Care Devices In UK 39
9.1 Diabetes Care Devices, UK, Overall Revenue ($ m), 2000-2015 39
9.2 Diabetes Care Devices, UK, Category Volume (Units), 2000-2015 43
9.3 Diabetes Care Devices, UK, Key Market Trends 45
9.3.1 Increasing Prevalence of Diabetes in UK to Drive the Market 45
9.3.2 Aging Population 46
9.3.3 High Obesity Prevalence and Sedentary Lifestyles 46
9.3.4 Home Diabetes Care Driving Growth 46
9.3.5 Remote Monitoring: Increasing Diabetic Compliance 47
9.3.6 Increasing Demand for Pain Free Insulin Delivery Devices 47
9.3.7 Emergence of Continuous Glucose Monitoring (CGM) to drive Growth in the Market 47
9.3.8 Drug Stores to Remain the Major Distribution Channels 48
9.3.9 High Cost of Insulin Pumps 48
9.4 Diabetes Care Devices, UK, Company Share (2007-2008) 49
10 Glucose Monitoring In UK 51
10.1 Glucose Monitoring Overall Revenue (2000-2015) 51
10.1.1 Blood Glucose Meters Overall Revenue (2000-2015) 53
10.2 Glucose Monitoring Overall Volume (2000-2015) 55
10.2.1 Blood Glucose Meters Overall Volume (2000-2015) 56
10.3 Glucose Monitoring Average Price (2000-2015) 57
10.4 Glucose Monitoring Market Dynamics 58
10.4.1 Market Drivers 58
10.4.2 Market Restraints 58
10.5 Glucose Monitoring Distribution Share (2007-2008) 59
10.6 Glucose Monitoring, UK, Company Share (2007-2008) 60
11 Insulin Delivery In UK 62
11.1 Insulin Delivery Overall Revenue (2000-2015) 62
11.1.1 Insulin Pens Overall Revenue (2000-2015) 66
11.2 Insulin Delivery Overall Volume (2000-2015) 68
11.2.1 Insulin Pens Overall Volume (2000-2015) 69
11.3 Insulin Delivery, UK, Cross-Segment Analysis, 2000-2015 71
11.4 Insulin Delivery Average Price (2000-2015) 72
11.5 Insulin Delivery Market Dynamics 73
11.6 Insulin Delivery Distribution Share (2007-2008) 74
11.7 Insulin Delivery, UK, Company Share (2007-2008) 75
12 Overview of Key Companies in UK Diabetes Care Devices Market 77
12.1 F. Hoffmann-La Roche Ltd. 77
12.1.1 Company Overview 77
12.1.2 F. Hoffmann-La Roche Ltd Pipeline Products 80
12.2 LifeScan, Inc. 81
12.2.1 Company Overview 81
12.2.2 LifeScan, Inc. Pipeline Products 81
12.3 Bayer HealthCare AG 82
12.3.1 Company Overview 82
12.3.2 Bayer HealthCare AG Pipeline Products 85
12.4 Abbott Laboratories 86
12.4.1 Company Overview 86
12.4.2 Abbott Laboratories Pipeline Products 89
12.5 Novo Nordisk A/S 90
12.5.1 Company Overview 90
12.5.2 Novo Nordisk A/S Pipeline Products 90
12.6 Becton, Dickinson and Company 92
12.6.1 Company Overview 92
12.7 Eli Lilly and Company 94
12.7.1 Company Overview 94
12.7.2 Eli Lilly and Company Pipeline Products 97
12.8 Medtronic, Inc. 98
12.8.1 Company Overview 98
12.8.2 Medtronic, Inc. Pipeline Products 100
12.9 ARKRAY, Inc. 103
12.9.1 Company Overview 103
12.10 Terumo Corporation 103
12.10.1 Company Overview 103
12.11 Animas Corporation 106
12.11.1 Company Overview 106
12.12 Sanofi-Aventis 106
12.12.1 Company Overview 106
12.13 Smiths Medical 107
12.13.1 Company Overview 107
13 Recent Developments 110
13.1 Strategy and Business Planning 110
13.1.1 Mar 25, 2009: Smiths Medical Intents To Stop Selling Deltec Cozmo Insulin Pumps 110
13.2 Government and Public Interest 111
13.2.1 Apr 29, 2009: Warning About Failing Insulin Infusion Pump, UK 111
13.3 Product News 112
13.3.1 Mar 19, 2009: Accu-Chek Inform II Blood Glucose Monitoring System Helps To Improve Patient Care 112
13.3.2 Feb 03, 2009: Accu-Chek Aviva Nano Designed To Motivate Patients For Self-Management Of Diabetes 113
14 Appendix 114
14.1 GlobalData Research Methodology 114
14.2 Secondary Research 115
14.3 Primary Research 116
14.4 Models 116
14.5 Forecasts 117
14.6 Expert Panel Validation 117
14.7 Currency Conversion 118
14.8 Contact Us 119
14.9 Disclaimer 119